Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.

SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases

Open access

Published version of a preprint

Abstract

Functional tumor-specific CD8+ T cells are essential for effective anti-tumor immune response and immune checkpoint inhibitor therapy. Here we show that, compared to other organ sites, primary, metastatic liver tumors in murine models contain a higher number of tumor-specific CD8+ T cells which are also dysfunctional. High-dimensional, multi-omic analysis of patient samples reveals a higher frequency of exhausted tumor-reactive CD8+ T cells and enriched interactions between these cells and SPP1+ macrophages in profibrotic, alpha-SMA rich regions specifically in the liver. Differential pseudotime trajectory inference analysis reveals that extrahepatic signaling promotes an intermediate cell (IC) population in the liver, characterized by co-expression of VISG4, CSF1R, CD163, TGF-βR, IL-6R, and SPP1. Analysis of premetastatic adenocarcinoma patient samples reveals enrichment of this population may predict liver metastasis. These findings suggest a mechanism by which extrahepatic tumors drive liver metastasis by promoting an IC population that inhibits tumor-reactive CD8+ T cell function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-025-59529-0

Cites

84 of 84 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Tumor-Antigen-Specific (TAS) CD8 T Cells Across Murine Models. A Frequency of AH1 + CD8 + T cells in liver and subcutaneous tumor-bearing mice compared to tumor free (TF) mice at days 7 (subcutaneous (s.q.), n = 5; intrahepatic (i.h.), n = 5, tumor injection), 14 (s.q., n = 5; i.h., n = 5) and 21(s.q., n = 5; i.h., n = 7) (i.h. liver vs i.h. TIL p < 0.0001; i.h. Spleen vs i.h. TIL p < 0.0001; s.q. liver vs s.q. TIL p < 0.0001; s.q. TIL vs s.q. spleen p < 0.0001; TF Liver vs TF Spleen p > 0.9999). B Photo showing excised subcutaneous and intrahepatic tumors across days 7 (i.h., n = 5; s.q., n = 5; TF, n = 5), 14 (i.h., n = 5; s.q., n = 5; TF, n = 5), and 21 (i.h., n = 7; s.q., n = 5; TF, n = 5). C Tumor weights at day 14 (p = 0.8320) and 21 (p = 0.0232) (i.h., n = 5; s.q., n = 5;). Mice were euthanized at 3 weeks when tumors had reached humane clinical endpoints, and, at day 21, the intrahepatic tumors had an average weight of 1.3 g while subcutaneous tumors weighed 0.3 g. D Frequency of AH1 + CD8 + T cells in various organs; i.h., n = 4; TV, n = 5; s.q., n = 6; TF, n = 5 (i.h. TIL vs s.q. liver p < 0.0001; i.h. TIL vs s.q. TIL p = 0.0047; i.h. liver vs s.q. liver p = 0.0212; i.h. liver vs TF liver p = 0.0361). E Representative flow cytometry plots of D. All experiments (A–E) were completed in female, BALB/c 6-8 week old mice. Data was analyzed using 2-way ANOVA for A and ordinary one-way ANOVA for C and D: *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).
Fig. 1 Tumor-Antigen-Specific (TAS) CD8 T Cells Across Murine Models. A Frequency of AH1 + CD8 + T cells in liver and subcutaneous tumor-bearing mice compared to tumor free (TF) mice at days 7 (subcutaneous (s.q.), n = 5; intrahepatic (i.h.), n = 5, tumor injection), 14 (s.q., n = 5; i.h., n = 5) and 21(s.q., n = 5; i.h., n = 7) (i.h. liver vs i.h. TIL p < 0.0001; i.h. Spleen vs i.h. TIL p < 0.0001; s.q. liver vs s.q. TIL p < 0.0001; s.q. TIL vs s.q. spleen p < 0.0001; TF Liver vs TF Spleen p > 0.9999). B Photo showing excised subcutaneous and intrahepatic tumors across days 7 (i.h., n = 5; s.q., n = 5; TF, n = 5), 14 (i.h., n = 5; s.q., n = 5; TF, n = 5), and 21 (i.h., n = 7; s.q., n = 5; TF, n = 5). C Tumor weights at day 14 (p = 0.8320) and 21 (p = 0.0232) (i.h., n = 5; s.q., n = 5;). Mice were euthanized at 3 weeks when tumors had reached humane clinical endpoints, and, at day 21, the intrahepatic tumors had an average weight of 1.3 g while subcutaneous tumors weighed 0.3 g. D Frequency of AH1 + CD8 + T cells in various organs; i.h., n = 4; TV, n = 5; s.q., n = 6; TF, n = 5 (i.h. TIL vs s.q. liver p < 0.0001; i.h. TIL vs s.q. TIL p = 0.0047; i.h. liver vs s.q. liver p = 0.0212; i.h. liver vs TF liver p = 0.0361). E Representative flow cytometry plots of D. All experiments (A–E) were completed in female, BALB/c 6-8 week old mice. Data was analyzed using 2-way ANOVA for A and ordinary one-way ANOVA for C and D: *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).CC BY · PubMed Central
Fig. 2 TAS CD8 + T cell phenotype and function. Frequency of (A) CD39 +, (C) Granzyme B +, (E) CD69+, and (G) Ki-67+ among TAS CD8+ T cells in the TIL, liver, and spleen of liver and subcutaneous tumor-bearing mice at days 7 (subcutaneous (s.q.), n = 5; intrahepatic (i.h.) tumor injection, n = 5), 14 (s.q., n = 5; i.h., n = 5) and 21(s.q., n = 5; i.h., n = 7). Comparison of (B) CD39+ (Liver p < 0.000001; TIL p = 0.000178), (D) Gzmb+ (Liver p = 0.000037; TIL p = 0.000413), (F) CD69+ (Liver p = 0.000404; TIL p = 0.012408); and (H) Ki-67+ (Liver p = 0.000032; TIL p = 0.168307) AH1 + to AH1- CD8 + T cells in the liver (left, n = 17) and TIL (right, n = 17) at day 14. I Tumor weights after either IgG or αCD8 T cell antibody treatment after intrahepatic (IgG, n = 7; αCD8, n = 8, p > 0.9999) or subcutaneous injection (IgG, n = 9; αCD8, n = 11, p = 0.0011) of tumor. All experiments (A–I) were completed in female, BALB/c 6-8 week old mice. Data was analyzed with unpaired two-sided t tests (B, D, F, H) and brown-forsythe and welch anova (I): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).
Fig. 2 TAS CD8 + T cell phenotype and function. Frequency of (A) CD39 +, (C) Granzyme B +, (E) CD69+, and (G) Ki-67+ among TAS CD8+ T cells in the TIL, liver, and spleen of liver and subcutaneous tumor-bearing mice at days 7 (subcutaneous (s.q.), n = 5; intrahepatic (i.h.) tumor injection, n = 5), 14 (s.q., n = 5; i.h., n = 5) and 21(s.q., n = 5; i.h., n = 7). Comparison of (B) CD39+ (Liver p < 0.000001; TIL p = 0.000178), (D) Gzmb+ (Liver p = 0.000037; TIL p = 0.000413), (F) CD69+ (Liver p = 0.000404; TIL p = 0.012408); and (H) Ki-67+ (Liver p = 0.000032; TIL p = 0.168307) AH1 + to AH1- CD8 + T cells in the liver (left, n = 17) and TIL (right, n = 17) at day 14. I Tumor weights after either IgG or αCD8 T cell antibody treatment after intrahepatic (IgG, n = 7; αCD8, n = 8, p > 0.9999) or subcutaneous injection (IgG, n = 9; αCD8, n = 11, p = 0.0011) of tumor. All experiments (A–I) were completed in female, BALB/c 6-8 week old mice. Data was analyzed with unpaired two-sided t tests (B, D, F, H) and brown-forsythe and welch anova (I): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).CC BY · PubMed Central
Fig. 3 scRNA-seq analysis of human tumor-reactive CD8 + T cells. A Schematic of scRNA-seq analysis to define potentially tumor-reactive (pTRT) CD8 + T cells using single-cell gene set enrichment analysis (scGSEA) and frequency of pTRT CD8 + T cells in various organs; hepatic metastasis, n = 10; hepatic surrounding tissue, n = 10; primary CRC tumor, n = 10; colon surrounding tissue, n = 10; PBMC, n = 10; lymph node, n = 9. Cell-type icons created with BioRender.com84. Frequency of pTRT that are found in each CD8 + T cell cluster in (B) hepatic metastisis (n = 10) compared to primary CRC tumor (n = 10). Frequency of pTRT that are found in each CD8 + T cell cluster in (C) hepatic surrounding tissue (n = 10), (D) colon surrounding tissue (n = 10), E) PBMC (n = 10) and (F) lymph node (n=9) with cluster labels found on the right of (C). CellChat cellular communication analysis for communications that the pTRT are sending to all major cell types, comparing hepatic metastasis to primary CRC tumors in the (G) number of interactions and (H) strength of interactions based on the law of mass action. All interactions that were found to be statistically greater in the hepatic metastasis (n = 10) are shown in red, and in the primary CRC tumor (n = 10) are shown in blue. Similarly, CellChat cellular communication analysis for communications that the pTRT are receiving from all major cell types, comparing the (I) number of interactions and (J) strength of interactions between hepatic metastasis to primary CRC tumors. CellChat cellular communication analysis for communications that the pTRT are sending to macrophage clusters, comparing hepatic metastasis to primary CRC tumors in the (K) number of interactions and (L) strength of interactions. M Schematic of CellChat pathway analysis comparing macrophage-pTRT CD8 + T cell interaction pathways upregulated in hepatic metastasis (n = 10) compared to primary CRC tumor (n = 10). Cell-type icons created with BioRender.com84. Data were analyzed using paired one-way anova analysis (mixed effect analysis) (A) and a paired Wilcox test (default for CellChat) (G–M) (data are presented as mean values +/− SEM).
Fig. 3 scRNA-seq analysis of human tumor-reactive CD8 + T cells. A Schematic of scRNA-seq analysis to define potentially tumor-reactive (pTRT) CD8 + T cells using single-cell gene set enrichment analysis (scGSEA) and frequency of pTRT CD8 + T cells in various organs; hepatic metastasis, n = 10; hepatic surrounding tissue, n = 10; primary CRC tumor, n = 10; colon surrounding tissue, n = 10; PBMC, n = 10; lymph node, n = 9. Cell-type icons created with BioRender.com84. Frequency of pTRT that are found in each CD8 + T cell cluster in (B) hepatic metastisis (n = 10) compared to primary CRC tumor (n = 10). Frequency of pTRT that are found in each CD8 + T cell cluster in (C) hepatic surrounding tissue (n = 10), (D) colon surrounding tissue (n = 10), E) PBMC (n = 10) and (F) lymph node (n=9) with cluster labels found on the right of (C). CellChat cellular communication analysis for communications that the pTRT are sending to all major cell types, comparing hepatic metastasis to primary CRC tumors in the (G) number of interactions and (H) strength of interactions based on the law of mass action. All interactions that were found to be statistically greater in the hepatic metastasis (n = 10) are shown in red, and in the primary CRC tumor (n = 10) are shown in blue. Similarly, CellChat cellular communication analysis for communications that the pTRT are receiving from all major cell types, comparing the (I) number of interactions and (J) strength of interactions between hepatic metastasis to primary CRC tumors. CellChat cellular communication analysis for communications that the pTRT are sending to macrophage clusters, comparing hepatic metastasis to primary CRC tumors in the (K) number of interactions and (L) strength of interactions. M Schematic of CellChat pathway analysis comparing macrophage-pTRT CD8 + T cell interaction pathways upregulated in hepatic metastasis (n = 10) compared to primary CRC tumor (n = 10). Cell-type icons created with BioRender.com84. Data were analyzed using paired one-way anova analysis (mixed effect analysis) (A) and a paired Wilcox test (default for CellChat) (G–M) (data are presented as mean values +/− SEM).CC BY · PubMed Central
Fig. 4 Spp1 + Macrophages cause TAS CD8 + T cell dysfunction. A Frequency of Spp1 + macrophages in intrahepatic (n = 8 mice) and subcutaneous TILs (n = 5 mice); p = 0.0016. B PDL1 + frequency of Spp1 + macrophages in intrahepatic (n = 8 mice) and subcutaneous TILs (n = 5 mice); p = 0.0428. C CD163 + CD206 + (M2) frequency of Spp1 + macrophages in intrahepatic (n = 8 mice) and subcutaneous TILs (n = 5 mice); p = 0.0019. D Correlation between orthotopic tumors and frequency of Spp1 + macrophages (n = 13). E Frequency of Spp1 + macrophages after hypoxia and normoxia (n = 4 mice); p =0.0186. F FN1 + frequency of macrophages after hypoxia and normoxia (n = 4 mice); p = 0.0466. G CD163 + CD206 + (M2) frequency of macrophages after hypoxia and normoxia (n = 4 mice); p = 0.0173. H Spp1 + macrophage expression of FN1 (MFI) after hypoxia and normoxia (n = 4 mice). Nanostring (I) T cell exhaustion, (J) JAKSTAT pathway, (K) MAPK, (L) NF-kB, and (M) TLR scores in IgG, Spp1, and Spp1 with anti-CD44 antibody (n = 6; box plots showing both replicates as bounds of box and center indicating mean). Experiments were completed in female, BALB/c 6–8 week old mice (A–H) and female, C57BL/6 6–8 week old mice (I–M). Data was analyzed using ordinary one way Anova (A–C), two-sided paired t test (E–H), simple linear regression (D): *P < 0.05; **P < 0.01; ***P < 0.005; ****P <0.001, ns = not significant (data are presented as mean values +/− SEM).
Fig. 4 Spp1 + Macrophages cause TAS CD8 + T cell dysfunction. A Frequency of Spp1 + macrophages in intrahepatic (n = 8 mice) and subcutaneous TILs (n = 5 mice); p = 0.0016. B PDL1 + frequency of Spp1 + macrophages in intrahepatic (n = 8 mice) and subcutaneous TILs (n = 5 mice); p = 0.0428. C CD163 + CD206 + (M2) frequency of Spp1 + macrophages in intrahepatic (n = 8 mice) and subcutaneous TILs (n = 5 mice); p = 0.0019. D Correlation between orthotopic tumors and frequency of Spp1 + macrophages (n = 13). E Frequency of Spp1 + macrophages after hypoxia and normoxia (n = 4 mice); p =0.0186. F FN1 + frequency of macrophages after hypoxia and normoxia (n = 4 mice); p = 0.0466. G CD163 + CD206 + (M2) frequency of macrophages after hypoxia and normoxia (n = 4 mice); p = 0.0173. H Spp1 + macrophage expression of FN1 (MFI) after hypoxia and normoxia (n = 4 mice). Nanostring (I) T cell exhaustion, (J) JAKSTAT pathway, (K) MAPK, (L) NF-kB, and (M) TLR scores in IgG, Spp1, and Spp1 with anti-CD44 antibody (n = 6; box plots showing both replicates as bounds of box and center indicating mean). Experiments were completed in female, BALB/c 6–8 week old mice (A–H) and female, C57BL/6 6–8 week old mice (I–M). Data was analyzed using ordinary one way Anova (A–C), two-sided paired t test (E–H), simple linear regression (D): *P < 0.05; **P < 0.01; ***P < 0.005; ****P <0.001, ns = not significant (data are presented as mean values +/− SEM).CC BY · PubMed Central
Fig. 5 Knock out Spp1 decreases TAS CD8 + T cell exhaustion and tumor burden. Symbol legend for (A–D) can be found in (D). A Frequency of CD39 + TRP2 + (TAS) CD8 + T cells (left; p = 0.0165) and CD39 + TRP2- (TAS) CD8 + T cells (right; p = 0.4001) in Spp1 KO compared to WT mice. B Frequency of TIM-3+ TRP2 + CD8 + T cells (left; p = 0.0464) and TIM-3 + TRP2- CD8 + T cells (right; p = 0.9834) in Spp1 KO (n = 6) compared to WT mice (n = 7). C Frequency of CD44 + CD62L- TRP2 + CD8 + T cells (left; p = 0.0338) and CD44 + CD62L- TRP2- CD8 + T cells (right; p = 0.3264) in Spp1 KO (n = 6) compared to WT mice (n = 7). D Frequency of CD44- CD62L + TRP2 + CD8 + T cells (left; p = 0.0229) and CD44- CD62L + TRP2- CD8 + T cells (right; p = 0.0986) in Spp1 knockout (KO) (n = 6) compared to WT mice (n = 7). E RIL-175 tumor weight comparing in Spp1 KO (n = 5) compared to WT mice (n = 5; p = 0.0428). Experiments (A–E) were completed in male and female B6.129S6(Cg)-Spp1tm1Blh/J 6–8 week old mice. Data was analyzed using 2-way Anova (A–D) and two-sided unpaired t test (E): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).
Fig. 5 Knock out Spp1 decreases TAS CD8 + T cell exhaustion and tumor burden. Symbol legend for (A–D) can be found in (D). A Frequency of CD39 + TRP2 + (TAS) CD8 + T cells (left; p = 0.0165) and CD39 + TRP2- (TAS) CD8 + T cells (right; p = 0.4001) in Spp1 KO compared to WT mice. B Frequency of TIM-3+ TRP2 + CD8 + T cells (left; p = 0.0464) and TIM-3 + TRP2- CD8 + T cells (right; p = 0.9834) in Spp1 KO (n = 6) compared to WT mice (n = 7). C Frequency of CD44 + CD62L- TRP2 + CD8 + T cells (left; p = 0.0338) and CD44 + CD62L- TRP2- CD8 + T cells (right; p = 0.3264) in Spp1 KO (n = 6) compared to WT mice (n = 7). D Frequency of CD44- CD62L + TRP2 + CD8 + T cells (left; p = 0.0229) and CD44- CD62L + TRP2- CD8 + T cells (right; p = 0.0986) in Spp1 knockout (KO) (n = 6) compared to WT mice (n = 7). E RIL-175 tumor weight comparing in Spp1 KO (n = 5) compared to WT mice (n = 5; p = 0.0428). Experiments (A–E) were completed in male and female B6.129S6(Cg)-Spp1tm1Blh/J 6–8 week old mice. Data was analyzed using 2-way Anova (A–D) and two-sided unpaired t test (E): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).CC BY · PubMed Central
Fig. 6 CODEX analysis of macrophage and CD8 + T cell interactions in αSMA rich regions. A Overview of whole-tissue section of human HCC sample with 37-plex CODEX panel. B Annotations (blue) of profibrotic αSMA + (red) regions. C Overlay of annotations (B) on whole-tissue section (A). D Single cell resolution annotation of macrophages and CD8 + T cells. E Representative spatial plot of macrophages proximity analysis to CD8 + T cells where macrophages within 100 µM of CD8 + T cells are labeled in red and macrophages farther than 100 µM of CD8 + T cells are labled in green. F) Macrophage density in αSMA + and αSMA- regions (n = 15 patients; p = 0.0957). G Macrophage proximity to CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p < 0.0001). H Macrophage proximity to Ki67 + CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.0127). I Macrophage proximity to CD45RA + CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.0014). J Macrophage proximity to CD45RO + CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.0032). K Macrophage proximity to CD39 + CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.0004). L Macrophage proximity to NK cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.5322). M CD8 + T cell proximity to NK cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.4420). N Macrophage proximity to Treg in αSMA + and αSMA- regions (n = 14 patients; p = 0.9391). O CD8 + T cell proximity to Tregs in αSMA + and αSMA- regions (n = 14 patients; p = 0.9003). Data was analyzed by two-sided paired t test (F-O): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).
Fig. 6 CODEX analysis of macrophage and CD8 + T cell interactions in αSMA rich regions. A Overview of whole-tissue section of human HCC sample with 37-plex CODEX panel. B Annotations (blue) of profibrotic αSMA + (red) regions. C Overlay of annotations (B) on whole-tissue section (A). D Single cell resolution annotation of macrophages and CD8 + T cells. E Representative spatial plot of macrophages proximity analysis to CD8 + T cells where macrophages within 100 µM of CD8 + T cells are labeled in red and macrophages farther than 100 µM of CD8 + T cells are labled in green. F) Macrophage density in αSMA + and αSMA- regions (n = 15 patients; p = 0.0957). G Macrophage proximity to CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p < 0.0001). H Macrophage proximity to Ki67 + CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.0127). I Macrophage proximity to CD45RA + CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.0014). J Macrophage proximity to CD45RO + CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.0032). K Macrophage proximity to CD39 + CD8 + T cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.0004). L Macrophage proximity to NK cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.5322). M CD8 + T cell proximity to NK cells in αSMA + and αSMA- regions (n = 15 patients; p = 0.4420). N Macrophage proximity to Treg in αSMA + and αSMA- regions (n = 14 patients; p = 0.9391). O CD8 + T cell proximity to Tregs in αSMA + and αSMA- regions (n = 14 patients; p = 0.9003). Data was analyzed by two-sided paired t test (F-O): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).CC BY · PubMed Central
Fig. 7 Exhausted, profibrotic polarization of the liver correlated to extrahepatic tumor signaling. AH1 + CD8 + T cells in the liver of subcutaneous tumor-bearing mice expressing CD39 (A; day 7 vs 14 p = 0.0083; day 7 vs 21 p < 0.0001; day 14 vs 21 p < 0.0001), TIM3 (B; day 7 vs 14 p = 0.0760; day 7 vs 21 p < 0.0001; day 14 vs 21 p < 0.0001), PD1 (C; day 7 vs 14 p < 0.0001; day 7 vs 21 p < 0.0001; day 14 vs 21 p < 0.0001), and CD69 (D; day 7 vs 21 p < 0.0001; day 14 vs 21 p < 0.0001). E Correlation of fibronectin expression in metastatic intrahepatic tumors (MT) to TGF-β and IL-6 in primary tumors (n = 10). F Correlation of fibronectin expression in primary CRC tumors (PT) to TGF-β and IL-6 in primary tumors (n = 10). G Correlation of SPP1 expression by macrophages in metastatic intrahepatic tumors (MT) to TGF-β and IL-6 expression in primary tumors (n = 10). H Correlation of SPP1 expression by macrophages in primary CRC tumors to TGF-β and IL-6 in primary tumors (n = 10). Data was analyzed with simple linear regression (E–H) and one-way Anova (A–D): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant.
Fig. 7 Exhausted, profibrotic polarization of the liver correlated to extrahepatic tumor signaling. AH1 + CD8 + T cells in the liver of subcutaneous tumor-bearing mice expressing CD39 (A; day 7 vs 14 p = 0.0083; day 7 vs 21 p < 0.0001; day 14 vs 21 p < 0.0001), TIM3 (B; day 7 vs 14 p = 0.0760; day 7 vs 21 p < 0.0001; day 14 vs 21 p < 0.0001), PD1 (C; day 7 vs 14 p < 0.0001; day 7 vs 21 p < 0.0001; day 14 vs 21 p < 0.0001), and CD69 (D; day 7 vs 21 p < 0.0001; day 14 vs 21 p < 0.0001). E Correlation of fibronectin expression in metastatic intrahepatic tumors (MT) to TGF-β and IL-6 in primary tumors (n = 10). F Correlation of fibronectin expression in primary CRC tumors (PT) to TGF-β and IL-6 in primary tumors (n = 10). G Correlation of SPP1 expression by macrophages in metastatic intrahepatic tumors (MT) to TGF-β and IL-6 expression in primary tumors (n = 10). H Correlation of SPP1 expression by macrophages in primary CRC tumors to TGF-β and IL-6 in primary tumors (n = 10). Data was analyzed with simple linear regression (E–H) and one-way Anova (A–D): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant.CC BY · PubMed Central
Fig. 8 Intermediate cell population secondary to metastatic signaling. Intrahepatic macrophage and monocyte population UMAP from metastatic CRC tumor-bearing liver, including macrophages (Mph) and monocytes (Mono) (A) (n = 10). Pseudotime trajectory analysis (n = 10) of intrahepatic macrophages and monocytes (B). Top branch of pseudotime analysis showing correlation of SPP1 (C), TGF-βR1 and IL6R (D), CSF1R and VSIG4 (E), and CD163 and CD206 (F) with pseudotime trajectories (n = 10). Subclustering of pseudotime branch related to SPP1 (n = 10) (G) with ridge plot displaying expression of CD163 (H), CD206 (I), VSIG4 (J), CSF1R (K), SPP1 (L), IL6R (M), TGF-βR1 (N), IL18 (O), pseudotime (P), positive collagen regulation score (Q), Kupfer cell (KC) score (R). S Frequency of cells coexpressing all markers of IC cluster in all macrophages and monocytes in the liver and the colon per patient (n = 10; p = 0.0156). T Intermediate cluster (IC) score calculated in CD68 + per group in non-pancreatic adenocarcinoma cancer patients (nonPAC), late liver metastasis (Late LiM), extrahepatic metastasis (EHM), early liver metastasis (early LiM). U Expression of fibronectin in metastatic intrahepatic tumor compared to primary CRC tumor (n = 10 patients;p = 0.0268). V Collagen type IV subunit A qPCR expression in the liver of tumor-free (n=5), subcutaneous tumor (n=5), and intrahepatic tumor-bearing (n = 8) 6–8 week old female, BALB/c mice (TF vs SQ p = 0.0037; TF vs IH p = 0.0276; SQ vs IH p = 0.0353). Data were analyzed with two-sided paired t test (S,U) and one-way anova (V): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).
Fig. 8 Intermediate cell population secondary to metastatic signaling. Intrahepatic macrophage and monocyte population UMAP from metastatic CRC tumor-bearing liver, including macrophages (Mph) and monocytes (Mono) (A) (n = 10). Pseudotime trajectory analysis (n = 10) of intrahepatic macrophages and monocytes (B). Top branch of pseudotime analysis showing correlation of SPP1 (C), TGF-βR1 and IL6R (D), CSF1R and VSIG4 (E), and CD163 and CD206 (F) with pseudotime trajectories (n = 10). Subclustering of pseudotime branch related to SPP1 (n = 10) (G) with ridge plot displaying expression of CD163 (H), CD206 (I), VSIG4 (J), CSF1R (K), SPP1 (L), IL6R (M), TGF-βR1 (N), IL18 (O), pseudotime (P), positive collagen regulation score (Q), Kupfer cell (KC) score (R). S Frequency of cells coexpressing all markers of IC cluster in all macrophages and monocytes in the liver and the colon per patient (n = 10; p = 0.0156). T Intermediate cluster (IC) score calculated in CD68 + per group in non-pancreatic adenocarcinoma cancer patients (nonPAC), late liver metastasis (Late LiM), extrahepatic metastasis (EHM), early liver metastasis (early LiM). U Expression of fibronectin in metastatic intrahepatic tumor compared to primary CRC tumor (n = 10 patients;p = 0.0268). V Collagen type IV subunit A qPCR expression in the liver of tumor-free (n=5), subcutaneous tumor (n=5), and intrahepatic tumor-bearing (n = 8) 6–8 week old female, BALB/c mice (TF vs SQ p = 0.0037; TF vs IH p = 0.0276; SQ vs IH p = 0.0353). Data were analyzed with two-sided paired t test (S,U) and one-way anova (V): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).CC BY · PubMed Central
Fig. 9 Spp1 knock out decreases metastatic burden. A Presence of RIL-175 metastatic liver tumor comparing in Spp1 KO (n = 5) compared to WT mice (n = 7); p = 0.0289. B Number of metastatic surface nodules comparing Spp1 KO (n = 5) compared to WT mice (n = 7); p = 0.0238. Experiments (A, B) were completed in male and female B6.129S6(Cg)-Spp1tm1Blh/J 6–8 week old mice. Data was analyzed using two-sided unpaired t test (A-B): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).
Fig. 9 Spp1 knock out decreases metastatic burden. A Presence of RIL-175 metastatic liver tumor comparing in Spp1 KO (n = 5) compared to WT mice (n = 7); p = 0.0289. B Number of metastatic surface nodules comparing Spp1 KO (n = 5) compared to WT mice (n = 7); p = 0.0238. Experiments (A, B) were completed in male and female B6.129S6(Cg)-Spp1tm1Blh/J 6–8 week old mice. Data was analyzed using two-sided unpaired t test (A-B): *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001, ns = not significant (data are presented as mean values +/− SEM).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 84 references

Cited by

Still being checked.

Metadata

Authors
Trehan, R., Huang, P., Zhu, X. B., Wang, X., Soliman, M., Strepay, D., Nur, A., Kedei, N., Arhin, M., Ghabra, S., Rodríguez-Matos, F., Benmebarek, M.-R., Ma, C., Korangy, F., & Greten, T. F.
Affiliations
National Institutes of Health (US)
Corresponding author
Greten, Tim F.
Venue
Nature Communications
Published
2025-05-07
Volume
16
Issue
1
Pages
4242-4242
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4410159530
Cited by
74
References
84
Citations by year
2026: 61 · 2025: 13
FWCI
30.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, public-domain)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, public-domain)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health & Human Services | NIH | National Cancer Institute (ZIA BC011345, ZO1 BC010870)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
SPP1+ macrophages, tumor-specific CD8+ T cells, T cell exhaustion, liver metastasis, tumor-infiltrating macrophages, tumor microenvironment, alpha-smooth muscle actin, TGF-beta signaling, immune checkpoint inhibitors, antitumor immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases. https://app.cochat.ai/papers/10.1038/s41467-025-59529-0
The paper
Trehan, R., Huang, P., Zhu, X. B., Wang, X., Soliman, M., Strepay, D., Nur, A., Kedei, N., Arhin, M., Ghabra, S., Rodríguez-Matos, F., Benmebarek, M.-R., Ma, C., Korangy, F., & Greten, T. F. (2025). SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases. Nature Communications. https://doi.org/10.1038/s41467-025-59529-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.